FDA — authorised 25 March 2003
- Application: BLA021106
- Marketing authorisation holder: PHARMACIA
- Local brand name: SOMAVERT
- Indication: INJECTABLE — SUBCUTANEOUS
- Status: approved
🇺🇸 Trovert in United States
FDA authorised Trovert on 25 March 2003
Marketing authorisations
FDA
- Status: approved
Trovert in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Trovert approved in United States?
Yes. FDA authorised it on 25 March 2003; FDA has authorised it.
Who is the marketing authorisation holder for Trovert in United States?
PHARMACIA holds the US marketing authorisation.